Lifetime risk of developing coronary heart disease
The LancetPublished 1 January 1999
Donald M. Lloyd‐Jones, Martin G. Larson, Alexa Beiser, Daniel Levy
Citations923
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Lifetime risk of developing coronary heart disease at age 40 years is one in two for men and one in three for women, even at age 70 years, and even atage 70 years it is oneIn three for menand one in four for women.
Abstract
Lifetime risk at age 40 years is one in two for men and one in three for women. Even at age 70 years it is one in three for men and one in four for women. This knowledge may promote efforts in education, screening, and treatment for prevention of coronary heart disease in younger and older patients.
Keywords
Medicine
New England Journal of MedicinePrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
7,453 Citations1995James Shepherd, Stuart M. Cobbe +6 more
Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.
The LancetAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
7,036 Citations1997Christopher J L Murray, Alan D López
Three scenarios of future mortality and disability for different age-sex groups, causes, and regions, developed as part of the Global Burden of Disease Study, found some robust results with implications for health policy.
Archives of Internal MedicineThe sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
5,669 Citations1997
JAMAPrimary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
5,269 Citations1998John R. Downs, Michael Clearfield +8 more
Lovastatin reduces the risk for the first acute major coronary event in men and women with average TC and LDL-C levels and below-average HDL- C levels and supports the inclusion of HDL-C in risk-factor assessment and the need for reassessment of the National Cholesterol Program guidelines.
The LancetGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
4,476 Citations1997Christopher J L Murray, Alan D López
The three leading contributors to the burden of disease are communicable and perinatal disorders affecting children, and the substantial burdens of neuropsychiatric disorders and injuries are under-recognised.
The LancetMortality by cause for eight regions of the world: Global Burden of Disease Study
4,064 Citations1997Christopher Murray, Alan D López
The Global Burden of Disease Study (GBD) used various data sources and made corrections for miscoding of important diseases (eg, ischaemic heart disease) to estimate worldwide and regional cause-of-death patterns in 1990, and the estimates by cause provide a foundation for a more informed debate on public-health priorities.
Archives of Internal MedicineThe Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
3,779 Citations1997
In older persons, diuretics are preferred and long-acting dihydropyridine calcium antagonists may be considered and specific therapy for patients with LVH, coronary artery disease, and heart failure are outlined.
HypertensionPrevalence of Hypertension in the US Adult Population
2,997 Citations1995Vicki L. Burt, Paul K. Whelton +6 more
awareness, treatment, and control of hypertension have improved substantially since the 1976-1980 National Health and Nutrition Examination Survey but continue to be suboptimal, especially in Mexican Americans.(ABSTRACT TRUNCATED AT 250 WORDS)
The LancetRandomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
2,994 Citations1997Jan A. Staessen, Robert Fagard +16 more
Among elderly patients with isolated systolic hypertension, antihypertensive drug treatment starting with nitrendipine reduces the rate of cardiovascular complications and may prevent 29 strokes or 53 major cardiovascular endpoints.
Annals of Internal MedicineHormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
2,353 Citations1992D Grady, Susan M. Rubin +6 more
American Journal of Public Health and the Nations HealthEpidemiological Approaches to Heart Disease: The Framingham Study
2,129 Citations1951Thomas R. Dawber, Gilcin F. Meadors +1 more
New England Journal of MedicinePostmenopausal Estrogen Therapy and Cardiovascular Disease
1,999 Citations1991Meir J. Stampfer, Graham A. Colditz +5 more
American Journal of EpidemiologyAN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
1,656 Citations1979William B. Kannel, Manning Feinleib +3 more
There is little evidence that coronary heart disease (CHD) experience and CHD risk factors differ in parents of those who volunteered for this study and the parents ofThose who did not volunteer.
New England Journal of MedicineThe Effect of Age on the Association between Body-Mass Index and Mortality
1,628 Citations1998June Stevens, Jianwen Cai +4 more
Excess body weight increases the risk of death from any cause and from cardiovascular disease in adults between 30 and 74 years of age and the relative risk associated with greater body weight is higher among younger subjects.
Preventive MedicineEstrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
1,601 Citations1991Meir J. Stampfer, Graham A. Colditz
The bulk of the evidence strongly supports a protective effect of estrogens that is unlikely to be explained by confounding factors and is consistent with the effect of Estrogen on lipoprotein subfractions.
Archives of Internal MedicineLifetime Risks of Hip, Colles', or Vertebral Fracture and Coronary Heart Disease Among White Postmenopausal Women
689 Citations1989Steven R. Cummings
This work used population-based data to estimate a woman's lifetime risk of suffering a hip, Colles', or vertebral fracture and her risk of dying of coronary heart disease.
JNCI Journal of the National Cancer InstituteThe Lifetime Risk of Developing Breast Cancer
635 Citations1993Eric J. Feuer, Lap‐Ming Wun +4 more
A revised method for calculating estimates of the lifetime risk of developing breast cancer and a conditional risk estimate over the short term (10 or 20 years) may be more reliable.
NeurologyLifetime risk of dementia and Alzheimer's disease
485 Citations1997Sudha Seshadri, P. A. Wolf +5 more
The actual remaining lifetime risk of AD or dementia varies with age, sex, and life expectancy and is lower than the hypothetical risk estimated by a cumulative incidence in the same population.
Journal of the American Statistical AssociationOn the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data
480 Citations1993Jeffrey J. Gaynor, Eric J. Feuer +6 more
Journal of the American College of CardiologyEditorial
279 Citations1997Herbert J. Levine
The question of whether human life can be extended by cardiac slowing remains moot and most likely will only be resolved by retrospective analyses of large populations, future animal studies and clinical trials using bradycardic therapy.
Journal of Chronic DiseasesSome methodologic problems in the long-term study of cardiovascular disease: Observations on the Framingham study
182 Citations1959Tavia Gordon, Felix E. Moore +2 more
It is shown that some important characteristics studied in the epidemiology of coronary heart disease are not altered permanently by the disease event and are considered trivial for prospective evaluation of hypotheses.
BMJA simple computer program for guiding management of cardiovascular risk factors and prescribing
119 Citations1999Aroon D. Hingorani, Patrick Vallance
This simple computer program to estimate individuals' cardiovascular disease risk and display the benefits of intervention should help clinicians and patients decide on the most effective packages of risk reduction and identify those most likely to benefit from modulation of risk factors.
American Journal of EpidemiologyEffect of Risk Factor Values on Lifetime Risk of and Age at First Coronary Event
70 Citations1995Gary E. Fraser, Kristian D. Lindsted +1 more
Journal of Epidemiology & Community HealthCancer incidence: life table risk versus cumulative risk.
62 Citations1994Leo J. Schouten, Huub Straatman +2 more
The life table method is convenient for estimating the probability that a person will develop cancer during a defined period or during his or her lifetime, and the other estimates overestimate the risk of the disease under investigation, especially in the very elderly.
PubMedProbability of developing or dying of cancer United States, 1991.
7 Citations1997Lawrence Garfinkel
Analyses of published data in the 1973-1991 Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Institute estimated a person's lifetime risk of developing or dying of cancer.